Concurrent cardiac surgery combined with non-cardiac surgery is also a feature of top-tier tertiary hospitals with strong comprehensive strength. To summarize the past cases, cardiac surgery is mainly coronary artery bypass, but also valve surgery; other non-cardiac simultaneous surgery, both benign lesions and more tumor surgery, related specialties include urology, thoracic surgery, general surgery, and even gynecology. If cardiac interventions (mainly coronary artery disease) are performed first, there is the disadvantage of intensive postoperative anticoagulation affecting other surgeries and delaying oncological treatment; while if oncological surgery is performed first, the high potential for cardiac events in the perioperative period plagues the surgeons and anesthesiologists involved. The advantage of co-located surgery is that one hospitalization, one anesthesia, and one surgery, i.e., “one-stop” medical service, addresses at least two aspects of the disease; at the same time, it also facilitates the management of perioperative anticoagulation. Today’s case is a severe three-branch lesion with non-stop coronary artery bypass grafting for three branches and lumpectomy for radical kidney cancer at the same time. In terms of the number of similar simultaneous combined surgeries, perioperative safety, and long-term prognosis, we have the most and the best in China.